| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 |
| filingDate |
1995-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722a73503cbaa915ab61ffd76e93cffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e60cf2027609c14228eef71602ded74c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780953c7d7b15d64173959ab25263f05 |
| publicationDate |
1996-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H08245415-A |
| titleOfInvention |
β-Transforming growth factor production promoter |
| abstract |
(57) [Summary] [Structure] A β-type transforming growth factor production promoter characterized by comprising interferon as an active ingredient. [Effect] By using the β-transforming growth factor production promoter of the present invention, TG of retinal pigment epithelial cells It can be used as a therapeutic agent for eye disease, retinal disease, and retinal choroidal disease by increasing Fβ1 production. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0878200-A4 |
| priorityDate |
1995-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |